Protein “Barcodes” Can Precisely Guide CAR T Cells to Targets
Children's Hospital of Philadelphia
Identifying peptide backbones that link protein complexes to cancer cells can help maximize CAR therapy applicability to different tumor types
Cancer
Introducing Today's Clinical Lab 2024 All Inclusive Pass
Today's Clinical Lab
Sign up for all of our 2024 digital events with one click
2024 Cancer Research & Diagnostics Digital Forum
Today's Clinical Lab
Join Today's Clinical Lab and our experts for our Cancer Research & Diagnostics Digital Forum on June 18, 2024
How Does AI Augment Predictive Cancer Research and Diagnosis?
Mateusz Tylicki, BSc
Deep learning and AI-based decisions are becoming increasingly reliable but remain far from being adapted to cancer diagnostics
FDA Approves First Drug Therapy for Desmoid Tumors
U.S. Food and Drug Administration
The FDA granted the approval of Ogsiveo to SpringWorks Therapeutics Inc.
New Approach to Using Immunotherapy Combinations in Bladder Cancer
Netherlands Cancer Institute
Nivolumab and gemcitabine–cisplatin combo showed significantly better outcomes than standard-of-care in patients with advanced urothelial carcinoma
RNA Expression Scores Predict Response to Bladder Cancer Therapy
SWOG Cancer Research Network
Prospective trials may help assess whether molecular subtype-directed approach can improve response to neoadjuvant therapy in MIBC patients
Combo Immunotherapy Trial for Glioblastoma Commences
University of North Carolina School of Medicine
New Drug for Relapsed Blood Cancer in First Human Trial
The James Cancer Hospital and Solove Research Institute (OSUCCC – James)
CLL makes up a quarter of leukemia cases among adults and NHL accounts for 4 percent of all cancers in the US
Breast Cancer Detection App Gets FDA's Breakthrough Device Designation
Swathi Kodaikal, MSc
The application is the first of its kind to be recognized by the FDA
ACS Updates Lung Cancer Screening Guideline
American Cancer Society
The Society aims to reduce lung cancer deaths with updated screening recommendations
Seeking KRAS: An Optimized Protocol for Detecting KRAS Mutations
Thermo Fisher Scientific
Discover how Sanger sequencing helps detect KRAS mutations to inform oncological treatment and prognosis
'Realizing Precision Cancer Medicine'
Miriam Bergeret, MSc
The November 2023 Cancer & Genomics issue of Today's Clinical Lab is now available!
Progress in Precision Oncology: AACR Cancer Progress Report 2023
Michael Schubert, PhD
Liquid biopsy, molecular profiling, and other recent advances from the AACR Cancer Progress Report 2023
December 6, 2023: Cancer & Genomics Digital Forum
Today's Clinical Lab
Join Today's Clinical Lab and our speakers for our Cancer & Genomics Digital Forum on December 6, 2023
Antibody-Drug Conjugate Benefits HER2-Low Breast Cancers
German Institute for Quality and Efficiency in Health Care (IQWiG)
Patients with HER2-low breast cancers were included in the clinical trial proving the efficacy of trastuzumab deruxtecan monotherapy
Treatment Combo Outperforms Standard-of-Care in Colorectal Cancer Trial
City of Hope
The novel therapeutic could provide a new option for patients with treatment-resistant KRAS gene mutation-positive colorectal cancer
FDA Approves New Therapeutic for Myelodysplastic Syndromes
U.S. Food and Drug Administration
Tibsovo can be used with FDA-approved companion diagnostic RealTime IDH1 Assay to detect and treat MDS
Blood Test to Detect Cancer Early in High-Risk Families
The Hospital for Sick Children
Liquid biopsies help extract and screen circulating tumor DNA for cancer-causing anomalies well in advance
Neoadjuvant Shows Positive Response in Advanced Melanoma Trial
SWOG Cancer Research Network
Single-agent immunotherapy shrinks over half of advanced melanomas when given before surgery